#Network Point-of-Care Glucose Testing Market Growth

[industrynewsupdates]

Network Point-of-Care Glucose Testing Market Size, Share And Trends Analysis Report

The global network point-of-care glucose testing market size is expected to reach USD 1.79 billion by 2030, registering a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Gather more insights about the market drivers, restrains and growth of the Network Point-of-Care Glucose Testing Market

Network Point-of-Care Glucose Testing Market Report Highlights

• Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring

• Based on product, the Accu-Chek Inform II segment dominated the market and accounted for a revenue share of 48.4% in 2023 and is expected to expand at a lucrative growth rate during the forecast period

• North America dominated the market with a revenue share of 40.7% in 2023 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate 

Network Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global network point-of-care glucose testing market on the basis of on product and region:

Network Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• i-STAT

• Accu-Chek Inform II

• StatStrip

• HemoCue

• CareSens Expert Plus

• BAROzen H Expert Plus

Network Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

• Latin America

o Brazil

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

List of Key Players in the Network Point-of-Care Glucose Testing Market

• Abbott, LLC

• Nova Biomedical

• Danaher

• F. Hoffmann-La Roche Ltd.

• Ascensia Diabetes Care Holdings AG

• Prodigy Diabetes Care, LLC

• Nipro Corporation Japan

• ACON Laboratories, Inc.

Order a free sample PDF of the Network Point-of-Care Glucose Testing Market Intelligence Study, published by Grand View Research.

[global-research-report]

Comprehensive Study on the Point-of-Care Glucose Testing Market

The global point-of-care glucose testing market size is expected to reach USD 4.51 billion by 2030, registering a CAGR of 4.1% over the forecast period, according to a new report by Grand View Research, Inc. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

Point-of-Care Glucose Testing Market Report Highlights

Accu-Chek Inform II accounted for the second-largest share in 2022 and is anticipated to maintain this trend throughout the forecast period

Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2023 to 2030

North America is the leading regional market due to the higher penetration of novel diagnostic techniques

Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics

Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market on the basis of product, and region:

PoC Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2030)

Accu Check Aviva Meter

Onetouch Verio Flex

i-STAT

Bayer CONTOUR Blood Glucose Monitoring System

Freestyle Lite

True Metrix

Accu-Chek Inform II

StatStrip

Others

PoC Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2030)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Saudi Arabia

South Africa

UAE

Kuwait

Order a free sample PDF of the Point-of-Care Glucose Testing Market Intelligence Study, published by Grand View Research.

[researchinhealthcare]

Test Strip Market 2021 – Global Industry Size, share, Business Insights, Growth Analysis, Recent Trends, Demands and Forecast By 2027

Test Strip Market Overview :

Test strip is a type of diagnostic devices which is the most important tools in Point of Care (POC) diagnostics. These test strip helps to achieve rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others with precsion.

Test strips are widely used for monitoring the blood glucose level in the diabetic patients. As per world Health Organization (WHO), it was estimated that in 2016, 420 million adult population is suffering from diabetes all over the world will and the number is expected to reach 625 million till 2040.

The global test strip market is growing with the dynamic pace. The global test strip market is expecting a sound growth at a CAGR of 12.8% during the forecasted period. Increasing prevalence of diabetes, and other urinary tract diseases has supported the growth of this market.

According to a recent study report published by the Market Research Future, The global test strip market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2021).

The market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region.

Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Test Strip Market Competitive Analysis :

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market.

The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/672

The global test strip market is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share.

For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Test Strip Industry Key Players :

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global Test Strip Market and are profiled in MRFR Analysis.

Report Details @ https://www.marketresearchfuture.com/reports/test-strip-market-672 .

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market Demand, Cost Analysis And Latest Advancement in Medical Sector 2027

Market Highlights:

According to MRFR analysis, the global point of care diagnostics/testing Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The global point of care diagnostics/testing market is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.

The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15 minutes. In June 2020, Celltrion Group (South Korea) announced to launch COVID-19 POC antigen testing kit. Furthermore, the prominent players focus on employee satisfaction, transforming their research utilities, and diversifying their distribution network. These factors will augment the market growth and will increase the market share during the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: North America is estimated to dominate the point of care diagnostics/testing market, owing to the increasing demand for virtual and convenient diagnostic solutions, enhancement in healthcare regulations, and growing awareness about wellness and healthcare among the young population. Furthermore, the involvement/adoption of strategies like mergers & acquisitions by key players, government partnerships, and the development of new products are also propelling the market growth. Europe embraces the second-largest position in the point of care diagnostics/testing market due to the increasing number of IVD testing, molecular diagnostics, and the prevalence of respiratory diseases across the region. The industry players are involved in various business activities such as product launches, mergers and acquisitions, partnerships, and other commercial approaches. For instance, in May 2020, ProciseDx (US) launched 510k filing for CRP test in Europe for gastrointestinal disorders. The product launch aims to offer high lab-quality results to the patients. In addition, in July 2021, QuantuMDx (Singapore) launched Q-POC, a point-of-care diagnostics to detect SARS-CoV-2. The product is easy to use, affordable, and offers results in 30 minutes. Such business parameters are expected to propel the point of care diagnostic market in the forecast period.

Asia-Pacific is projected to be the fastest-growing regional market during the study period due to increasing demand for diagnostic tests such as blood gas tests, rapid blood coagulation tests, pregnancy tests, drug abuse screening, rapid diagnosis of cardiac markers, blood glucose testing, electrolyte analysis, urine analysis, and dry biochemical tests across the region. In addition, the increasing demand for multiple diagnostic devices coupled with the rising demand for accurate and efficient diagnostic and testing devices is driving the Asia-Pacific point of care diagnostics market.

The growth of the market in the Rest of the World is gaining importance over the last few years due to the increasing diagnosis of HbA1c and growing demand for glycated hemoglobin analysis. Moreover, the rising number of COVID-19 cases across the region is supporting the demand for POCs diagnosis. In addition, increasing investment in healthcare device manufacturing facilities is strengthening the product portfolio of the regional and global healthcare providers. The escalating demand for in-vitro diagnostics in South America is fueling the sales of POCs across the region. Such factors are expected to augment the market growth over the assessment period.

Segmentation:

The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[healthcaremarketreports]

Network Point-of-Care Glucose Testing Market Opportunities and Challenges

The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Some of the key industry participants are F. Hoffmann-La Roche Ltd., Abbott and Nova Biomedical. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Request a free sample copy or view report summary: Network Point-of-Care Glucose Testing Market Report

Network Point-of-Care Glucose Testing Market Report Highlights

Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring

Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period

North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

[marketresearchstrategy]

Etanercept Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027

The Global Etanercept  Market research report published by Reports and Data offers a comprehensive evaluation of the Etanercept  market on the global scale and sheds light on the growth opportunities, prospects, and enables the readers to formulate strategic plans. The report also provides insightful data about the market capacities, technological advancements, R&D developments, and other key features influencing market growth. The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional segmentation. The report also offers relevant and useful information to help the new entrants and established companies strengthen their market position.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1610

The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data. It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans. It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other. The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.

Key Manufacturers in the Global Etanercept  Market:

Pfizer Inc.

Celltrion Inc.

Immunex Corporation

Novartis International AG

GlaxoSmithKline Pharmaceuticals Ltd.

Hoffmann-La Roche Ltd.

Takeda Pharmaceutical Company Ltd.

Samsung Bioepis Co. Ltd.

Cipla

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1610

The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions. It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region. The report also offer a country-wise analysis to impart a better understanding of the revenue growth of the market in each region.

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Market segment based on product:

Enbrel

Benepali

Market segment based on application:

Rheumatoid arthritis

Psoriatic arthritis

Ankylosing spondylitis

Juvenile idiopathic arthritis (JIA)

Others

To know more about the report @ https://www.reportsanddata.com/report-detail/etanercept-market

Key Questions Addressed in the Report:

What is the market size the global Etanercept  market is expected to reach over the forecast period? What is the expected CAGR?

What are the key segments of the market?

What are the key products and applications of the Etanercept  market?

What factors are expected to drive and restrain market growth over the forecast period?

What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1610

Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more and our team will ensure the report is well suited to meet your requirements.

Browse More Details:

Point of care glucose testing market

Horgans on chips market

[delightfulconnoisseurgentlemen]

Blood Glucose Testing Devices Market Insight and Forecast to 2026 | Roche, LIFESCAN, Abbott, Ascensia, ARKRAY, I-SENS

"

Request a Sample

Reporthive.com Investigate presents an up-to-date study on “Blood Glucose Testing Devices market sales revenue for 2021, key player analysis, state of development, opportunity assessment, and forecast to 2026“. The report contains market forecasts related to future global estimates, share, business forecast, current manufacturers scenario, competitive landscape and forecast (2021-2026) and other material factors. With in-depth analysis and insight into the developments affecting the business, this report included detailed information on businesses on the global and regional levels. The data examined was conducted taking into account the current top players and the next competitors.

The Blood Glucose Testing Devices Industry Worldwide Report is an exceptional report that enables the industry to make strategic decisions and achieve growth goals. The analysis in this report has been used to examine the various reliable sectors for the fastest development based on the estimated forecasting framework.

Download Free Sample Copy of ‘Blood Glucose Testing Devices market’ Report @ https://www.reporthive.com/request_sample/2706217

Thinking is a step forward

In today’s competitive world, you need to think a step ahead to chase your competitors, as our research provides reviews on key players, important collaborations, unions, and acquisitions along with innovation trends and trade policies to provide a better understanding of driving business forward. Right direction.

The Blood Glucose Testing Devices Market Report is a veritable source of access to research data that is expected to significantly grow your business. The report provides information such as economic scenarios, earnings, limits, trends, market growth rates, and numbers. A SWOT analysis of the Blood Glucose Testing Devicess market and a Porters Five analysis are also incorporated into the report. Staying informed of market trends and drivers is crucial for decision makers to take advantage of this emerging opportunity. The study provides information on trends and development in the Blood Glucose Testing Devices market, drivers, capabilities, technologies, and the changing investment structure of the market.

The following companies are major contributors to the Blood Glucose Testing Devicess Market Research Report: Roche LIFESCAN Abbott Ascensia ARKRAY I-SENS Omron B. Braun Nipro Dagnostics 77 Elektronika AgaMatrix Infopia ALL Medicus Terumo SANNUO Yicheng Yuwell Edan

How will this report benefit potential stakeholders?

It provides figurative estimates for 2021 based on recent developments and historical data [2015-2020]. To collect information and estimate revenue for all sectors, the researchers used top-down and bottom-up approaches. On the basis of data gathered from primary and secondary research and reliable data sources, the report will help both new and current aspirants in the Blood Glucose Testing Devices market to discover and study market needs, market size and competition.

NB: We can also provide a market report in regional language, German / French / Japanese. We have investigated the COVID-19 situation thoroughly and the new sample has been updated to reflect the impact of COVID-19 on industry trends.

Partition Type: ☑ Glucose Oxidase, Glucose Dehydrogenase

Segmentation of industrial applications: ☑ Hospitals, Clinics, Household

Geographical analysis

The market research report for Blood Glucose Testing Devices provides a detailed analysis of the various regions and also contains a detailed analysis of the country. Besides the market revenues, the market value report also provides the forecast analysis for countries and regions. The report covers different geographic regions such as North America (USA and Canada), Asia Pacific (China, Japan and India), Europe (UK, Germany, France), Latin America (Mexico and Brazil), the Middle East and Africa. (Gulf Cooperation Council countries and South Africa).

The report sheds light on various aspects of the Blood Glucose Testing Devicess market and answers related questions about the Blood Glucose Testing Devicess market:

• What are the best investment opportunities to introduce new products and provide advanced services in the Blood Glucose Testing Devicess market? • What customer or related market value propositions should the company focus on when launching new research or mutual funds in the Blood Glucose Testing Devicess market? • What policy changes will help stakeholders enhance the supply chain and demand network? • Which areas will need more products and services in specific sectors during the forecast period? • What strategies have helped established players reduce supplier, procurement and logistics costs? • Will you use the prospect of using C-Suite to lead companies on a new growth path? • What government measures stimulate the Blood Glucose Testing Devices market or what government regulations might call into question the state of the regional and global industry in the Blood Glucose Testing Devices market? • How will the political and economic crisis affect opportunities in the growth areas of personal cosmetic personal care products?

>>> To get Incredible Discounts on this Premium Report, Click Here @ https://www.reporthive.com/2706217/check_discount

TOC Highlights:

Chapter 1. Introduction: The Blood Glucose Testing Devices research work report covers a concise introduction to the global market. This segment provides assessments of key participants, a review of Blood Glucose Testing Devices industry, outlook across key areas, financial services, and various difficulties faced by Blood Glucose Testing Devices Market. This section depends on the Scope of the Study and Report Guidance.

Chapter 2. Outstanding Report Scope: This is the second most significant chapter, which covers market segmentation along with a definition of Blood Glucose Testing Devices. It characterizes the whole scope of the Blood Glucose Testing Devices report and the various features it is describing.

Chapter 3. Market Dynamics and Key Indicators: This chapter incorporates key elements focusing on drivers [Includes Globally Growing Blood Glucose Testing Devices frequency and Increasing Investments in Blood Glucose Testing Devices], Key Market Restraints[High Cost of Blood Glucose Testing Devices], opportunities [Arising Markets in Developing Countries] and introduced in detail the arising trends [Consistent Innovate of New Screening Products] development difficulties, and influence factors shared in this latest report.

Chapter 4. Type Segments: This Blood Glucose Testing Devices market report shows the market development for different kinds of products showcased by the most far-reaching organizations.

Chapter 5. Application Segments: The analysts who composed the report have completely assessed the market capability of key applications and perceived future freedoms.

Chapter 6. Geographic Analysis : Each provincial market is deliberately examined to understand its current and future development, improvement, and request situations for this market.

Chapter 7. Impact of COVID-19 Pandemic on Global Blood Glucose Testing Devices Market: 7.1 North America: Insight On COVID-19 Impact Study 2021-2026 7.2 Europe: Serves Complete Insight On COVID-19 Impact Study 2021-2026 7.3 Asia-Pacific: Potential Impact of COVID-19 (2021-2026) 7.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

Chapter 8. Manufacturing Profiles: The significant players in the Blood Glucose Testing Devices market are definite in the report based on their market size, market served, products, applications, regional development, and other variables.

Chapter 9. Estimating Analysis: This chapter gives price point analysis by region and different forecasts.

Chapter 10. North America Blood Glucose Testing Devices Market Analysis: This chapter includes an appraisal on Blood Glucose Testing Devices product sales across major countries of the United States and Canada along with a detailed segmental viewpoint across these countries for the forecasted period 2021-2026.

Chapter 11. Latin America Blood Glucose Testing Devices Market Analysis: Significant countries of Brazil, Chile, Peru, Argentina, and Mexico are assessed apropos to the appropriation of Blood Glucose Testing Devices.

Chapter 12. Europe Blood Glucose Testing Devices Market Analysis: Market Analysis of Blood Glucose Testing Devices report remembers insights on supply-demand and sales revenue of Blood Glucose Testing Devices across Germany, France, United Kingdom, Spain, BENELUX, Nordic, and Italy.

Chapter 13. Asia Pacific Excluding Japan (APEJ) Blood Glucose Testing Devices Market Analysis: Countries of Greater China, ASEAN, India, and Australia & New Zealand are assessed, and sales evaluation of Blood Glucose Testing Devices in these countries is covered.

Chapter 14. Middle East and Africa (MEA) Blood Glucose Testing Devices Market Analysis: This chapter centers around Blood Glucose Testing Devices market scenario across GCC countries, Israel, South Africa, and Turkey.

Chapter 15. Research Methodology The research procedure chapter includes the accompanying primary realities, 15.1 Coverage 15.2 Secondary Research 15.3 Primary Research

Chapter 16. Conclusion

>>> Make an enquiry before buying this report @ https://www.reporthive.com/2706217/enquiry_before_purchase

Why Report Hive Research:

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SME’s, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc.

Contact Us:

Report Hive Research 500, North Michigan Avenue, Suite 6014, Chicago, IL – 60611, United States Website: https://www.reporthive.com Email: sales@reporthive.com Phone: +1 312-604-7084

"

[anettrolikova]

mRNA technology can be deployed against more than just viruses. Both Moderna and BioNTech have personalized vaccine candidates targeting cancer. Although called a “cancer vaccine,” the treatment is only administered once the subject has cancer—it isn’t preventative.

DeepMind’s protein-folding breakthrough signals a promising decade for the science of proteomics. Most directly, being able to predict protein shapes will enable us to discover drugs more rapidly. Buuuut, because drug trials take many years, we might expect this technology not to really be felt by the general public until the 2030s.

the rejuvenating aspects of young blood experiments were due to the dilution of harmful factors in old blood. By mechanically removing plasma and replacing it with saline and enough albumin to replace what was taken out, they diluted aged blood factors in both mice and humans and were able to rejuvenate germ layer tissues and improve cognition by reducing neuroinflammation.

Therapeutic plasma exchange is FDA-approved (not for aging, but for a bunch of other conditions). I imagine there remain prohibitions on advertising that it can add years to your life, but it is safe, and a doctor can prescribe it off label. It’s also cheap. An automated plasmapheresis machine—which lets you do treatment after treatment—can be bought online for under $3,000. That is less than the cost of a single transfusion of young blood sold by the startup Ambrosia. How long until someone opens a clinic offering plasma dilution?

longevity product that is about to get hot: aging clocks based on DNA methylation or proteomics. Do you want to know how biologically old you are? Today, for a few hundred dollars, you can get a test that will tell you. As these tests become better and cheaper, self-experimenters are going to have a field day. Doing before-and-after aging tests, anyone who can get their hands on human growth hormone could replicate the protocol used by Fahy et al. to rejuvenate the thymus. As the thymus is a critical element of the immune system, decline of which is a critical factor in aging, this is non-trivial rejuvenation. The Fahy study found that 12 months of treatment created about 2.5 years of epigenetic rejuvenation, with results accelerating in the last quarter of the trial.

biotech observation: every year, the Apple Watch gets a new health-related sensor. This year it was blood oxygen, pretty good for detecting if you might have COVID! Fast forward to 2030 and wearables will have at least 10 more health-related sensors than they do today. Some no-brainers are body temperature, blood pressure, and blood glucose sensors. What will the other 7 be? At some point, it becomes possible to replace a lot of primary care with continuous monitoring. A few smart algorithms to provide simple medical advice could improve population-level health without much cost. More data could also yield faster, more accurate, and of course more remote diagnoses when you do have to see a doctor.

Biology is proceeding faster than medical productivity because a lot of the wonderful discoveries are not being translated into approved treatments and products at a decent rate

this decade is enhanced and advanced geothermal systems. The legacy geothermal industry is sleepy, tapping energy at traditional volcanic hydrothermal hotspots—forget about it. The next generation of the industry, however, is a bunch of scrappy startups manned by folks leaving the oil and gas industry

the thing about electric cars: they are better than regular cars. They have lower fuel costs. They have fewer moving parts and thus lower maintenance costs. They have higher low-end torque and faster acceleration. If you mainly drive to and from work and have a charger at home, you never have to stop for gas. Electric cars will win because they are better, and the shift will happen suddenly.

One area where batteries may not work (aside from aviation, already discussed) is trucking. Towing really heavy loads requires a lot of energy—hydrogen fuel cells will be more suited to interstate trucking. The transition from diesel to hydrogen in trucking will likely not be as automatic as the transition from gas to batteries in cars. It’s possible that truckers will need a bit of a push.

a nationwide hyperloop network—is unlikely by 2030, even the 150-mph version is worth following. The time and hassle cost of travel is an important input into the gravity model of trade. I expect the DC-Baltimore Loop to significantly increase economic activity between the two cities—especially helping to revitalize Baltimore, as it would become easier to live there and work in DC.

When launch is expensive, more engineering has to go into the payload to ensure reliability. You don’t want to spend $1.8 billion on launch, and then find out, as NASA did with the Hubble Space Telescope, that your new satellite needs repairs. This dynamic has caused over-engineering of space payloads. With launch for a new low price of $10-20/kg, companies and research agencies will be able to reduce engineering expenses by simply taking on the risk of paying for another (cheap) launch.

The 2020s will be the decade that makes or breaks cryptocurrency. Well, nothing will ever break cryptocurrency—true believers will run the networks forever no matter what. But for cryptocurrency to have long-run value, I still hold that it needs to have mainstream uses. This means it needs to scale, it needs a good user experience, and normal people need to actually use it to transact. If it can’t reach that point by the end of the decade, I think it will have failed to have lived up to its promise. I am still cautiously optimistic. I think migration to proof-of-stake, lower transaction costs, more refined tools, and mature standards could lead to mainstreaming.

vertical farming. The combination of LED lights, cheap electricity (for water pumps), direct-use geothermal heating, and smart machine learning algorithms that determine optimal nutrient distribution could yield better produce than conventionally farmed vegetables at competitive prices. By removing pesticides, optimizing varieties for nutrition and flavor instead of hardiness on the supply chain, and ensuring quick delivery to market, vertical farms could supply a healthier and more delicious future of food. Speaking of food, I predict plant-based “meat” will flop, but lab-grown real meat is worth keeping an eye on. Until then, eat humanely-raised grass-finished cows.

[market-research-future]

Test Strip Market Insights, Solutions and Services

Test Strip Market Size, Growth and Share Analysis by Application (Diagnosis {Urinalysis [UTI, Liver Disease]} Pregnancy Test) Type (Fluorescein, Diabetic Strips, Urine test strip) End Users (Consumers, Hospitals, Clinics, Diagnostic Laboratories) - Volume & Value Forecast to 2021

Overview

The global test strip Market share is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share. For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/820

Test strip is a type of diagnostic devices which is the most important tools in Point of Care (POC) diagnostics. These test strip helps to achieve rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others with precsion. Test strips are widely used for monitoring the blood glucose level in the diabetic patients. As per world Health Organization (WHO), it was estimated that in 2016, 420 million adult population is suffering from diabetes all over the world will and the number is expected to reach 625 million till 2040. The global test strip market is growing with the dynamic pace.

The test strip Market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region. Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Increasing prevalence of diabetes, and other urinary tract diseases has supported the growth of this market. According to a recent study report published by the Market Research Future, The global test strip market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2021).

The global Test Strip Market is expecting a sound growth at a CAGR of 12.8% during the forecasted period. The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market. The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

Browse Detailed Table of Content at: https://www.marketresearchfuture.com/reports/test-strip-market-672

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Test Strip Market Competitive Analysis

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global test strip Market and are profiled in MRFR Analysis.

Brows More Healthcare Related Research Reports:

Medical Billing Market Size, Trends | Growth Analysis, 2023

Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR

Transradial Access Devices Market Research Report –Global Forecast to 2023| MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

[businessconsultingarticle]

Point of Care (PoC) Diagnostics Market to Reflect Significant Growth during 2020-2027

The Global Point of Care (PoC) Diagnostics Market research report offers accurate insights for the growth prospects of the Point of Care (PoC) Diagnostics market in the forecast years 2020-2027. The report is an all-inclusive study of the Point of Care (PoC) Diagnostics market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.

Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic. The global public health emergency has disrupted the lives of everyone across the globe. It has also had a substantial impact on the Point of Care (PoC) Diagnostics industry as global supply chains have been disrupted, and the financial scenario is tight. The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.

Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Scope of the Market Report: The report offers a holistic overview of the Point of Care (PoC) Diagnostics industry that offers all the essential information. Furthermore, the market is segmented into product types, applications, end-user industries, and regions. The report is formulated by extensive primary and secondary research and backed by the verified data from industry experts and professionals. It also sheds light on the market size and analyzes the market position. Along with this, the report extensively studies the competitive landscape in the market and profiles the key players of the industry.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Abbott, F. Hoffmann-La Roche and Siemens Healthineers.

For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook:

Product Type (Revenue, USD Million; 2016–2026)

Glucose Monitoring Products

Strips

Meters

Lancets & Lancing Devices

Cardiometabolic Testing Products

Cardiac Marker Testing Products

Blood Gas/Electrolytes Testing Products

HBA1C Testing Products

Prescription Mode (Revenue, USD Million; 2016–2026)

Prescription-based Testing

OTC Testing

End User (Revenue, USD Million; 2016–2026)

Professional Diagnostic Centres

Clinical Laboratories (Outpatient Healthcare &     Ambulatory Care Settings)

Hospitals/Critical Care Centres

Home Care

Research Laboratories

Other End Users

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1507

Additionally, the report covers an analysis of the key market regions where the market has substantial size and share. Along with the regions, the report also offers a country-wise analysis to enable better comprehension of the market competition. The key regions covered in the report are as follows:

North America     (U.S., Canada)

Europe     (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific     (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America     (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Summary of the Report:

The report offers a growth estimate for 8 years along     with a forecast for market valuation

A thorough qualitative and quantitative analysis of the     Global Point of Care (PoC) Diagnostics Market

Advanced analytical tools such as SWOT analysis and     Porter’s Five Forces analysis along with feasibility analysis and     investment return analysis

Comprehensive study of the prominent players engaged in     the market along with their product portfolio and business expansion strategies

Strategic recommendations for new entrants and     established players

Extensive analysis of drivers, restraints, limitations,     growth prospects and opportunities, and threats

In-depth regional analysis to offer a panoramic view of     the Point of Care (PoC) Diagnostics market along with a better     understanding of the market’s competitive scenario

To read more about the report, visit @ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Thank you for reading our report. The customization of the report is available as per your research needs. Please get in touch with us, and our team will ensure you get the report tailored as per your requirements.

Similar Report:

1. Urinalysis Market Size, Trends & Analysis, By Product, By Application, By End-Use Vertical, By Region, Segment Forecasts To 2027

2. Diagnostic Biomarkers Market Size, Trends & Analysis, By Product, By Form and By Application, Forecasts To 2027

[nicolasmatamoros6675]

Self-Testing Market – Insights on Emerging Scope 2027

Self-Testing Market: Overview

Self-testing market gained striking momentum from the vast uptake of HIV self-testing (HIVST) around the world. HIVST gathered immense momentum on the back of the demand for potentially cost-effective and rapidly diagnostic capability of the devices. In general, the demand in the self-testing market has been spurred by the increasing focus of healthcare systems to motivate those who would otherwise not undergo any test. Key benefits that attract users include scalability, cost-effectiveness, and apt knowledge about the usage among the health care users.

A wide range of applications in the self-testing market are in fertility self-test, menopause self-test, ovulation self-test, cholesterol and triglycerides tests, and pregnancy self-tests. Pregnancy self-test strips have gained widespread acceptance in developing economies. Another self-testing modality that has gained worldwide popularity is diabetes and glucose self-tests. Major forms in which self-testing are available are kits, strips, and devices.

For Right Perspective & Competitive Insights on Self -Testing Market, Request for a Sample

Self-Testing Market: Competitive Analysis and Key Developments

In the wake of rising COVID-19 pandemic, governments world over are grappling on approaches on improving the SARS-CoV-2 detection rate in the population. Countries with an inadequate healthcare infrastructure are in desperate attempt to fuel testing of the novel Coronavirus in countries to counter the spikes in cases. Even in an emerging economy such as in India, researchers have pinned great hopes on recent developments in self-testing market. An instance is the prospect of home-based midnasal swab collection. According to a research letter in the Journal JAMA Network Open, this self-testing modality for COVID-19 has comparable efficacy to clinic-based nasopharyngeal swab collection.

The key motivations spurring interest in this home-based self-testing technology is intense need for reducing the risk to healthcare professionals when the healthcare are already overburdened with Coronavirus-positive patients. This technology, the researchers assert, will boost access to testing, and will prove a boon in controlling the spread of COVID-19.

Some of the promising players in the self-testing market are B. Braun Holding GmbH, Johnson & Johnson, Geratherm Medical AG, Accuquik, Piramal Enterprises, OraSure Technologies, Inc, Nectar Lifesciences Limited, SelfDiagnostics OÜ, and PRIMA Lab SA. Top players are aspiring to spend on research and development of novel diagnostics.

Self-Testing Market: Key Trends

The changing attitudes and perceptions of healthcare workers and caregivers toward acceptance of self-testing modality and home-based tests is a key trend boosting the self-testing market. A striking trend has been positive attitude towards HIV self-testing, reinforcing sales of such technologies. In this regard, the high disease burden especially in less developed parts of the world has mounted the concern for getting vulnerable populations to undergo testing.

The demand for reducing the burden of testing of various chronic diseases with clinical settings is a notable trend boosting the self-testing market. The growing interest in infectious disease specialists has also expanded the avenue for for medical device manufacturers. Rise in uptake of self-testing kits in infections and allergies has also boosted revenue generation for players in the self-testing market.

Self -Testing Market: Regional Assessment

Some of the potentially lucrative regions in the self-testing market are North America, Asia Pacific excluding Japan, Japan, Western Europe, Eastern Europe, Latin America, the Middle-East and Africa. Of these, North America and Europe are promising markets. The lucrativeness of these regional markets have been reinforced by the rising preference of self-testing for chronic and other diseases, notably for diabetes, allergies, and pregnancy.

On the other hand, Asia Pacific is emerging as a potentially attractive market for manufacturers of self-testing market. The vast penetration of self-testing kits in various populations in the region has imparted a string push to the avenues in the overall market. A large chunk of the opportunities in recent years is found in China and India.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Request For Covid19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78416

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

Customer Experience Maps

Insights and Tools based on data-driven research

Actionable Results to meet all the business priorities

Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

North America

Asia Pacific

Europe

Latin America

The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

You May Also Like PRNewswire on https://www.prnewswire.com/news-releases/sake-brewery-industry-to-play-a-positive-role-in-cubitainers-market-growth-from-2020-to-2028-transparency-market-research-301104740.html

You May Also Like PRNewswire on https://www.prnewswire.com/news-releases/penetration-of-advanced-technologies-to-bring-a-paradigm-shift-in-growth-of-warranty-management-system-market-north-america-to-add-numerous-feathers-of-growth-opines-tmr-301110185.html

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

[jayanthitbrc]

Diabetes Care Devices Market Strategic Assessment, Future Development, Trends 2020 -2030: Covid 19 Impact And Recovery

The Business Research Company published its Diabetes Care Devices Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global diabetes care devices market. The report covers the diabetes care devices market’s segments- by type: blood glucose test strips; insulin pens, syringes, pumps and injectors; lancing devices and equipment; continuous glucose monitoring devices and equipment; blood glucose meters, by end user: hospitals and clinics; diagnostic laboratories; others, by type of expenditure: public; private, and by product: instruments/equipment; disposables subsegments covered: glucose dehydrogenase; glucose oxidase; pens; injectors and pumps; syringes.

View Complete Report: https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report-2020-30-covid-19-implications-and-growth

Diabetes Care Devices Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM) and transmits this information to an insulin pump that calculates and releases the required amount of insulin into the body. It consists of three essential components – a glucose sensor system, a control algorithm, and an insulin infusion device.  This system is more effective than conventional insulin delivery devices as it automates insulin dosing based on blood sugar levels.

Request A Sample “Diabetes Care Devices Market” Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3143&type=smp Few Points From Table Of Content 1. Executive Summary 2. Report Structure 3. Diabetes Care Devices Market Characteristics 4. Diabetes Care Devices Market Product Analysis 5. Diabetes Care Devices Market Supply Chain .................. 20. Diabetes Care Devices Market Competitive Landscape 21. Key Mergers And Acquisitions In The Diabetes Care Devices Market 22. Market Background: Medical Equipment Market 23. Recommendations  24. Appendix  Few Points From List Of Table Table 1: Historic Market Growth, Value ($ Billion) Table 2: Forecast Market Growth, Value ($ Billion) Table 3: Global Diabetes Care Devices Market, 2019, By Region, Value ($ Billion) .................... Table 134: Global Diabetes Care Devices Market In 2023- Growth Countries Table 135: Global Diabetes Care Devices Market In 2023- Growth Segments Table 136: Global Diabetes Care Devices Market In 2023- Growth Strategies About The Business Research Company: The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information: The Business Research Company https://www.thebusinessresearchcompany.com Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow us on Blog: http://blog.tbrc.info/  Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

[jigneshthanki-blog]

A Comprehensive Analysis on Internet of Medical Things (IoMT) Implementation in 2019

Although the healthcare industry has been slower at adopting the technologies associated with the Internet of Things, the growth that it will bring by 2021 will still be in the billions, according to Allied Market Research; $136.8 billion to be exact.

The transformation that the Internet of Medical Things (IoMT) technology will bring to the healthcare sector will not only be beneficial to patients, but it will create a demand for better treatment options, it will streamline workflow optimization within delivery systems, and it will decrease healthcare costs by providing better healthcare outcomes. With over 3.7 million medical devices currently in use, we are poised to see this number dramatically increase as IoMT connected devices and IoMT implementation continues to create ultimate IoMT technology solutions in the medical industry.

TOP 7 Categories We Will See Expand Healthcare via IoMT Solutions:

1. Fitness Wearables Will Continue to be Popular

It is without a doubt that fitness wearables and trackers will continue to be popular as more consumer options are being manufactured to have built-in sensors that collect physical-related data. We may see more smartwatches being made, wristbands, and smart apparel like Under Armour’s smart shoes. Leveraging wearable app development technology, these wearable devices empower the individuals to keep track of their health. Precise healthcare can be administered based on the computation of the collected data through mobile applications.

2. Wearable Devices Will Expand to Clinical Use

Unlike consumer wearables and trackers, clinical grade wearables will be specifically manufactured for the use of improving specific ailments and chronic conditions. They will take the form of smart belts and chest straps which can detect falls, protect hips, and record heart rate, respiratory rate, and temperature.

3. Remote Monitoring for Patients May Become the Norm

For patients who have acute or chronic diseases, remote patient monitoring devices can help them with recovery time, prevent re-admission, and improve their outcome as they can be observed even after being discharged. Beyond this, remote patient monitoring devices can over access to telemedicine, ensure a patient is adhering to medication and recovery plans, and even alter or change medication regimens at regular intervals without a face-to-face meeting. IoMT based patient healthcare mobility solutions will tremendously cater remote patient care enhancing user experience with instant and on demand doctor consultation.

4. Smart Pills May Be Put to Use

The idea behind smart pills is to help healthcare providers keep track of medication compliance. Each smart pill has an ingestible sensor within it which activates upon coming into contact with stomach fluids. When the pill is consumed, the data gets transferred to an arm patch which then updates on a smartphone application. This IoMT based Smart Pill is incredibly beneficial to caregivers who are taking care of patients who are suffering from mental diseases, where compliance can be hard to track (like Alzheimer’s).

5. Healthcare Will Be Closer to Patients Via Point of Care Devices

For individuals who live in remote locations, where access to healthcare may be less accessible, may be able to use point of care devices. These devices would provide preliminary screening procedures, eliminate laboratory setups for tests, and help test for baseline conditions such as drug abuse, infectious diseases, pregnancy, and glucose/cholesterol problems. These devices would be portable and could be placed in community centers as self-serving kiosks, creating an automation-like process. This would increase hospital workflow, automate registration processes, and can be used in conjunction with telemedicine.

6. Clinical Devices Will Become Smart Devices

The use of digital clinical devices, like digital stethoscopes, could be used to record and store patient’s vitals within the electronic health records. All data would be uploaded and stored to the cloud for later review, be shared with specific healthcare consultants, and allow caregivers to wirelessly deploy point of care options to patients.

7. Smart Hospitals Will Rise Up

Although all digital devices within hospitals are already considered IoMT, having them interconnected with one another will allow for better patient monitoring, increased workflow optimization, and can be used to manage hospital staff. If monitoring and tracking devices were implemented, inventory management, identification, and patient flow could be optimized.

Are There Challenges in Store for IoMT Implementation?

As the Internet of Medical Things (IoMT) becomes more widespread across hospital networks, there will certainly be implementation challenges.

a) There Will be Standardization Problems

When we take a look at medical devices on the market today, we see hundreds of thousands of vendors and manufacturers, all of which are scaling up production, cutting time to market, and pushing to make products available. So where does standardization come into play? Without it, these medical devices will be less effective as they may not adhere to FDA guidelines.

b) Regulatory Challenges Will be Abundant

As new clinical-grade medical devices are prototyped, manufactured, and produced, there will be new challenges for legislators who are in charge of creating regulations. Although there is regulation around patient health information, there are very few laws around medical devices that capture this information.

c) It Will Take High Infrastructure Costs

The cost associated with implementing cloud computing, creating healthcare apps, and installing the necessary hardware to ensure smooth communication between interconnected devices will have high costs. The initial investment for smart hospitals will be quite high and may be a barrier for years to come.

d) There Will Be Data Security Threats

Unfortunately, healthcare data is susceptible to cyber attacks, breaches, and hackers who want to secure the data and sell it. In using IoMT, there will be a greater likelihood of data theft, increased data exposure, and an increase of data breaches from both internal and external sources.

e) Data Handled Improperly Will Be Unusable

If the data that is collected by IoMT devices is not pooled and computed in a clinically relevant way, then the results will be negligible. In order to properly utilize the benefits of the Internet of Medical Things, the data needs to be relayed across all providers and payers.

Despite the fact that there are some obvious challenges for the widespread adoption of the applications in Internet of Medical Things (IoMT), the benefits and enlightenment that these devices can bring to the healthcare sector holds massive weight. Beyond being able to extend the reach of telemedicine, IoMT devices will streamline hospital workflow management, will positively impact patient outcomes, and will optimize healthcare processes, subsequently decreasing healthcare & insurance costs as well.

Have an awesome idea to enhance doctor and patient experience through a secure, robust and scalable solution? Talk to our IoMT experts to know more about IoMT solutions.

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market -Latest Trends, Demand, Growth, Opportunities and Outlook Till 2027

Market Highlights:

According to MRFR analysis, the global point of care diagnostics/testing Industry is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The global point of care diagnostics/testing market is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.

The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15 minutes. In June 2020, Celltrion Group (South Korea) announced to launch COVID-19 POC antigen testing kit. Furthermore, the prominent players focus on employee satisfaction, transforming their research utilities, and diversifying their distribution network. These factors will augment the market growth and will increase the market share during the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: North America is estimated to dominate the point of care diagnostics/testing market, owing to the increasing demand for virtual and convenient diagnostic solutions, enhancement in healthcare regulations, and growing awareness about wellness and healthcare among the young population. Furthermore, the involvement/adoption of strategies like mergers & acquisitions by key players, government partnerships, and the development of new products are also propelling the market growth.

Europe embraces the second-largest position in the point of care diagnostics/testing market due to the increasing number of IVD testing, molecular diagnostics, and the prevalence of respiratory diseases across the region. The industry players are involved in various business activities such as product launches, mergers and acquisitions, partnerships, and other commercial approaches. For instance, in May 2020, ProciseDx (US) launched 510k filing for CRP test in Europe for gastrointestinal disorders. The product launch aims to offer high lab-quality results to the patients. In addition, in July 2021, QuantuMDx (Singapore) launched Q-POC, a point-of-care diagnostics to detect SARS-CoV-2. The product is easy to use, affordable, and offers results in 30 minutes. Such business parameters are expected to propel the point of care diagnostic market in the forecast period.

Asia-Pacific is projected to be the fastest-growing regional market during the study period due to increasing demand for diagnostic tests such as blood gas tests, rapid blood coagulation tests, pregnancy tests, drug abuse screening, rapid diagnosis of cardiac markers, blood glucose testing, electrolyte analysis, urine analysis, and dry biochemical tests across the region. In addition, the increasing demand for multiple diagnostic devices coupled with the rising demand for accurate and efficient diagnostic and testing devices is driving the Asia-Pacific point of care diagnostics market.

The growth of the market in the Rest of the World is gaining importance over the last few years due to the increasing diagnosis of HbA1c and growing demand for glycated hemoglobin analysis. Moreover, the rising number of COVID-19 cases across the region is supporting the demand for POCs diagnosis. In addition, increasing investment in healthcare device manufacturing facilities is strengthening the product portfolio of the regional and global healthcare providers. The escalating demand for in-vitro diagnostics in South America is fueling the sales of POCs across the region. Such factors are expected to augment the market growth over the assessment period.

Segmentation:

The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[marketresearchstrategy]

Erythropoietin Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027

The Global Erythropoietin Market research report published by Reports and Data offers a comprehensive evaluation of the Erythropoietin market on the global scale and sheds light on the growth opportunities, prospects, and enables the readers to formulate strategic plans. The report also provides insightful data about the market capacities, technological advancements, R&D developments, and other key features influencing market growth. The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional segmentation. The report also offers relevant and useful information to help the new entrants and established companies strengthen their market position.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1607

The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data. It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans. It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other. The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.

Key Manufacturers in the Global Erythropoietin Market:

Johnson & Johnson

Celltrion, Inc.

Teva Pharmaceutical Industries Ltd.

Amgen Inc.

Hoffman-La Roche Ltd.

LG Life Sciences Ltd.

Biocon Limited

Intas Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Dr. Reddy's Laboratories Ltd.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1607

The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions. It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region. The report also offer a country-wise analysis to impart a better understanding of the revenue growth of the market in each region.

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Market segment by drug class:

Biologics

Biosimilars

Market segment by product type:

Epoetin-alfa

Epoetin-beta

Darbepoetin-alfa

And others

To know more about the report @ https://www.reportsanddata.com/report-detail/erythropoietin-epo-drugs-market

Key Questions Addressed in the Report:

What is the market size the global Erythropoietin market is expected to reach over the forecast period? What is the expected CAGR?

What are the key segments of the market?

What are the key products and applications of the Erythropoietin market?

What factors are expected to drive and restrain market growth over the forecast period?

What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1607

Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more and our team will ensure the report is well suited to meet your requirements.

Browse More Details:

Point of care glucose testing market

Horgans on chips market

[expertofmarketinsights-blog]

Lateral Flow Assay Market Trends Estimates High Demand by 2026

Lateral flow assay (LFA) offers simple, low-cost, rapid, point-of-care detection and quantification of analytes in complex mixtures, within 5-30 min. Low development costs and ease of operation of LFAs are results into expansion of its application in biomedicine, agriculture, veterinary, food safety and drug development. High prevalence of infectious disease and increasing adoption of lateral flow assay device in hospitals, physician’s clinics and clinical laboratories for the qualitative and quantitative detection of specific antigen and antibodies is expected to drive growth of lateral flow assay market over the forecast period. Click To Read More On Lateral Flow Assay Market

Market Dynamics

The global lateral flow assay market is projected to witness significant growth over the forecast period, owing to growing adoption of lateral flow assay in various applications including clinical diagnostics, drug development, quality testing, veterinary diagnostic, food and environmental testing, micronutrient monitoring, diagnosing invasive pulmonary aspergillosis, qualitative and quantitative detection of specific antigens and antibodies, and gene amplification. For instance, according to the American Pharmaceutical Association (APhA) Academy of Student Pharmacists: Resolutions Committee-2015 report, 8,856 community pharmacies have a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver, which enables pharmacists to perform POC tests such as glucose measurement and other POC testing. Moreover, increasing adaptation of point-of-care testing in clinical diagnosis and integration of POC testing in lateral flow assay tests are expected to drive growth of the lateral flow assay market over the forecasted period. However, variance or inconsistency results by lateral flow assay would lead to lower adoption of the technology, which in turn would hinder the growth of lateral flow assay market.

Increasing adoption of home-based lateral flow assay test are driving growth of the lateral flow assay market

Increasing prevalence of lifestyle and infectious diseases rising the demand for point-of-care testing under home care settings which has the ability to provide result in real-time (5-15 minutes), and ease of use. The home pregnancy test is well recognized example of lateral flow assay technology, which detects the presence of a hormone produced during pregnancy and displays a binary result. Adoption of home-based lateral flow assay devices is increasing, owing to various features such as portable device, low production cost, immediate results, and overall ease of use. Lateral flow assay based point-of-care testing improves the quality of care, owing to various advantages offered by them such as cost savings, reduced doctor, visits and laboratory overhead costs. However, variance in lateral flow assay test results may hinder growth of the lateral flow assay market.

High prevalence of infectious disease is expected to drive growth of the lateral flow assay market

High prevalence and increasing incidence of infectious disease are the major factors driving growth of the lateral flow assay market. According to the study published in journal Lancet Infectious Disease, in 2017, around 54,984,661 cases of 45 infectious diseases were reported with average yearly incidence 417·98 per 100?000 in china between January 2004 and December 2013. Furthermore, Hepatitis B and tuberculosis has shown high incidence rate of 81.57 and 80.33 per 100,000, respectively. Moreover, World Health Organization (WHO) estimated 212 million malaria cases worldwide in 2015, with highest incidence in African regions.

Key players operating in market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Inc., Qiagen N.V., Becton, Dickinson and Company, Diagnostic Consulting Network, Inc., Tetracore, Inc., Humasis Co. Ltd., and F. Hoffmann-La Roche AG.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1147

In the field of on-site diagnostics, lateral flow assay (LFA) are well-established commercial product due to their ability of providing precise, fast, and low-cost result such as home-based pregnancy tests. Lateral flow assay technology are rapidly evolved over the years and routinely used for point-of-care and companion diagnostic applications. Moreover, technological advances to transform the assays from simple qualitative tests into complex multi-analyte quantitative assay are driving growth of the lateral flow assay market. Lateral flow assay market is projected to witness growth over the forecast period, owing to increasing application in medical diagnostics, high prevalence of infectious disease, increasing demand for point-of-care testing, and high adoption of home-based lateral flow assay test. The global lateral flow assay market was valued at US$ 5.6 billion in 2017 and is expected to witness a CAGR of 7.5% over the forecast period (2017 – 2025).

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com